# Intas Pharmaceuticals Limited - Inspection Records

Source: https://www.keypedia.com/companies/intas-pharmaceuticals-limited/0db00702-d7f6-4a8b-87d1-1b32ac236cc8

> Inspection records and compliance data for Intas Pharmaceuticals Limited in Ahmedabad, None. Access full analysis and detailed observations.

---

## Details

- Name: Intas Pharmaceuticals Limited
- FEI Number: 3003157498
- City: Ahmedabad
- State: None
- Country Name: India
- Address Line 1: 218p - Chacharwad, 458 - Matoda; Sarkhej Gandhi Nagar Highway
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE

## Related Documents

- [WARNING_LETTER - Intas Pharmaceuticals Limited - 2025-09-17](https://www.keypedia.com/records/warning_letter/intas-pharmaceuticals-limited/5823afb5-cd04-4920-9a5a-ce851b44651c) — source: FDA, date: September 17, 2025
- [483 - Intas Pharmaceuticals Limited - 2025-02-14](https://www.keypedia.com/records/483/intas-pharmaceuticals-limited/6c44efff-a243-4cd8-b3e1-d79aa6443242) — source: FDA, date: February 14, 2025
- [FDA Inspection 1245599 - Intas Pharmaceuticals Limited - 2024-07-12](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/b7786616-f193-421d-81ca-40e09d86547d) — classification: No Action Indicated (NAI), source: FDA, date: July 12, 2024
- [483 - Intas Pharmaceuticals Limited - 2024-01-24](https://www.keypedia.com/records/483/intas-pharmaceuticals-limited/6496e826-9590-4ab3-a942-cc73428a9a15) — source: FDA, date: January 24, 2024
- [483 - Intas Pharmaceuticals Limited - 2023-12-07](https://www.keypedia.com/records/483/intas-pharmaceuticals-limited/fb102838-718b-4e34-a970-2af5219b3940) — source: FDA, date: December 7, 2023
- [483 - Intas Pharmaceuticals Limited - 2023-05-12](https://www.keypedia.com/records/483/intas-pharmaceuticals-limited/f0a0a214-afa3-42a9-8e03-f437d8972141) — source: FDA, date: May 12, 2023
- [483 - Intas Pharmaceuticals Limited - 2023-05-12](https://www.keypedia.com/records/483/intas-pharmaceuticals-limited/439bcecd-27da-49d0-b32b-ce7d8d990792) — source: FDA, date: May 12, 2023
- [FDA Inspection 1206170 - Intas Pharmaceuticals Limited - 2023-05-12](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/cc06d269-7eb7-476e-8b4c-d7dbea9b39ff) — source: FDA, date: May 12, 2023
- [483 - Intas Pharmaceuticals Limited - 2022-12-02](https://www.keypedia.com/records/483/intas-pharmaceuticals-limited/aaef987c-6382-4641-8d0e-9fc48ace87ba) — source: FDA, date: December 2, 2022
- [483 - Intas Pharmaceuticals Limited - 2019-08-02](https://www.keypedia.com/records/483/intas-pharmaceuticals-limited/d8b8b922-c242-4064-89d5-38ff992edec5) — source: FDA, date: August 2, 2019
- [FDA Inspection 1098380 - Intas Pharmaceuticals Limited - 2019-08-02](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/0895eb6a-065a-49a6-ac84-da712eda4358) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 2, 2019
- [483 - Intas Pharmaceuticals Limited - 2018-12-14](https://www.keypedia.com/records/483/intas-pharmaceuticals-limited/d7d4f9f0-3246-4bd4-b45d-b1149c0a717e) — source: FDA, date: December 14, 2018
- [FDA Inspection 1074349 - Intas Pharmaceuticals Limited - 2018-12-14](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/9fbc901d-b132-4d7d-9fdf-8ac222f2fec6) — classification: No Action Indicated (NAI), source: FDA, date: December 14, 2018
- [483 - Intas Pharmaceuticals Limited - 2018-06-08](https://www.keypedia.com/records/483/intas-pharmaceuticals-limited/f04937d8-44eb-46c2-bbcd-556a932a8455) — source: FDA, date: June 8, 2018
- [FDA Inspection 1056170 - Intas Pharmaceuticals Limited - 2018-06-08](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/40778dca-3416-4505-9b4f-98131521219b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 8, 2018
- [FDA Inspection 978469 - Intas Pharmaceuticals Limited - 2016-06-17](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/3aaf3f2a-46fc-4904-a72f-b656172dc11e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 17, 2016
- [FDA Inspection 923354 - Intas Pharmaceuticals Limited - 2015-04-07](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/493332f9-a20f-4012-b808-81c974265ac5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 7, 2015
- [FDA Inspection 839384 - Intas Pharmaceuticals Limited - 2013-06-21](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/3256955b-4ca2-4d12-9fa7-e98cbd2bad27) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 21, 2013
- [FDA Inspection 788126 - Intas Pharmaceuticals Limited - 2012-05-19](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/41c90e10-2e80-408d-a5b6-f5679faecf3e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 19, 2012
- [FDA Inspection 755788 - Intas Pharmaceuticals Limited - 2011-10-10](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/a82b265d-a4b3-4045-9edc-3a8726ce9811) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 10, 2011

## Related Companies

- [Biocon Biologics Limited](https://www.keypedia.com/companies/biocon-biologics-limited/7eb84509-8dc4-4765-9a0e-d2f65781328d)
- [RK Pharma Inc.](https://www.keypedia.com/companies/rk-pharma-inc/04d6c855-6dac-45ed-8597-0541bddd3bce)
- [Eugia SEZ Private Limited](https://www.keypedia.com/companies/eugia-sez-private-limited/c458dd25-5620-40af-93fe-f25936ff47e8)
- [Shilpa Medicare Limited](https://www.keypedia.com/companies/shilpa-medicare-limited/9184777f-89bb-4a33-bcb2-4cc2aa4eb655)
- [Eugia Pharma Specialities Limited](https://www.keypedia.com/companies/eugia-pharma-specialities-limited/9733456f-3189-4fe6-a4f9-327f0ce92559)
- [GlaxoSmithKline Biologicals](https://www.keypedia.com/companies/glaxosmithkline-biologicals/98ade6fb-8ae1-48af-a7cf-71b26cd2e808)
- [Evonik Corporation](https://www.keypedia.com/companies/evonik-corporation/f88f3afa-3508-4fc2-8d70-8558ece37d59)
- [Mankind Pharma Limited](https://www.keypedia.com/companies/mankind-pharma-limited/448ddf49-4ff4-4a2b-8444-e8cc23677777)
- [Teyro Labs Private Limited](https://www.keypedia.com/companies/teyro-labs-private-limited/8744f9fc-f440-4610-ac34-05b15c46173b)
- [Catalent Maryland, Inc.](https://www.keypedia.com/companies/catalent-maryland-inc/b2f722ce-b6bd-42e6-b648-cec5c4b5f44d)

## Related Officers

- [Quality System Specialist](https://www.keypedia.com/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)
- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [Asen Karapetyan](https://www.keypedia.com/people/asen-karapetyan/68f75825-0dcc-4fe5-9551-650cdd26dde7)
- [Matthew Casale, Investigator](https://www.keypedia.com/people/matthew-casale-investigator/6d265e1b-4375-4702-af40-8315ff4a267d)
- [FDA_PERSONNEL](https://www.keypedia.com/people/kirti-maheshwari-chief-technical-officer/9b82c3f1-cc04-4f60-bd6a-652f24fac524)